|
Market Closed -
London S.E.
23:35:18 26/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 12,234.00 GBX | -1.94% |
|
+1.53% | -11.28% |
| 12:18am | Daiichi Sankyo, AstraZeneca start phase 3 Datroway trial | AN |
| 12:03am | FTSE 100 drifts lower as eyes turn to Nvidia | AN |
Chart: Technical Analysis
Stock exchange
London S.E.
AZN 12,234.00 p
-1.94%
24.04B
p
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| AZN | 165.77USD | -2.29% | 210M $ | |
London S.E.
| AZN | 12,234.00GBX | -1.94% | 24.04B p | |
NYSE
| AZN | 169.66USD | +1.77% | 586M $ | |
|
Nasdaq Stockholm
| AZN | 1,588.00SEK | -1.31% | 791M kr | |
|
CBOE
| AZN | 12,250.00GBX | -1.73% | 3.53B p | |
|
CBOE
| AZNs | 1,587.00SEK | -1.37% | 316M kr | |
|
CBOE
| AZN | 165.84USD | -2.23% | 7.43M $ | |
|
Tradegate
| ZEG | 142.35EUR | -2.00% | 574K € | |
|
Mexican S.E.
| AZN1 N | 2,717.48MXN | +0.68% | 4.2M $ | |
|
Deutsche Boerse AG
| ZEG | 141.05EUR | -3.19% | 129K € | |
|
CBOE
| AZN | 1,583.00SEK | -1.59% | 815K kr | |
|
Börse Stuttgart
| ZEG | 142.40EUR | -1.79% | 64.08K € | |
|
Boerse Muenchen
| ZEG | 142.25EUR | -2.07% | 28.73K € | |
|
Berne S.E.
| 000982352 | 134.60CHF | +0.22% | 23.55K CHF | |
Buenos Aires S.E.
| AZN | 67,800.00ARS | +1.50% | 63.87M $ | |
|
Buenos Aires S.E.
| AZND | 44.24USD | +2.17% | 7.48K $ | |
Sao Paulo
| A1ZN34 | 142.50BRL | +0.09% | 12.26K R$ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Neutral |
| Resistance | 13,134 | 13,134 | 15,542 |
| Spread/Res. | -6.85% | -6.85% | -21.28% |
| Spread/Supp. | +6.75% | +6.75% | +11.22% |
| Support | 11,460 | 11,460 | 11,000 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AZN Stock
- Charts AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
